XORTX THERAPEUTICS INC (XRTX)
CA98420Q3061 - Common Stock
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...
XORTX Announces Publication of Key Research in ADPKD
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Welcomes New Member to the Board of Directors
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Announces New Clinical Advisory Board Member
CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
New York, NY, March 19, 2024 – (Plato Data) -- In the realm of pharmaceutical innovation, XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), stands out for its significant achievements in 2023 and ambitious plans for 2024. XORTX, a late-stage clinical pharmaceutical firm specializing in revolutionary treatments for progressive kidney disease, has made headlines with its tremendous progress.
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
CALGARY, Alberta, March 19, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 04, 2024 (GLOBE NEWSWIRE) --...
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) --...
XORTX Announces $2 Million Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Jan. 15, 2024 (GLOBE NEWSWIRE) --...
XORTX stock rallies 26% on patent application submission (NASDAQ:XRTX)
XORTX Therapeutics (XRTX) stock rallied 26% on news the company has submitted a patent application for the treatment of chronic kidney disease. Read more here.
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
CALGARY, Alberta, Jan. 03, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Welcomes New Member to the Board of Directors
CALGARY, Alberta, Jan. 02, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX announces $3.70M US ATM offering (NASDAQ:XRTX)
XORTX Therapeutics announces At The Market offering agreement with H.C. Wainwright & Co.
XORTX Announces US ATM Offering
CALGARY, Alberta, Nov. 30, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Meets Nasdaq Continued Listing Requirements
CALGARY, Alberta, Nov. 29, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Clarifies Timing for Share Consolidation
CALGARY, Alberta, Nov. 10, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Announces Share Consolidation
CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Announces Results of Special Meeting of Shareholders
CALGARY, Alberta, Oct. 27, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
CALGARY, Alberta, Oct. 25, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
XORTX Announces Rescheduling of Special Meeting of Shareholders
CALGARY, Alberta, Oct. 25, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to know about this morning!
Okta Stock Continues to Fall Following Security Breach
Okta stock is still falling on Monday as the company's shares suffer after it revealed a data breach of customer information.
Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?
Xortx Therapeutics stock is falling on Monday as the pharmaceutical company's shares retreat from a massive rally on Friday.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning!
Why Are Solar Stocks Down Today?
Solar stocks are down on Friday and investors can look to Deutsche Bank are the reason for the slump in the sector today.
Why is Webuy Global (WBUY) Stock Down 29% Today?
Webuy Global stock is losing ground on Friday after shares of WBUY stock underwent a major rally during the company's public debut yesterday.